Fingerprint
Dive into the research topics of 'A phase II study of imatinib mesylate and capecitabine in metastatic breast cancer: Southwest oncology group study 0338'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A phase II study of imatinib mesylate and capecitabine in metastatic breast cancer: Southwest oncology group study 0338
Helen Chew, William Barlow, Kathy Albain, Danika Lew, Allen Gown, Daniel Hayes, Julie Gralow, Gabriel Hortobagyi, Robert Livingston
Research output: Contribution to journal › Article › peer-review
32
Scopus
citations